Clinical trials
Active, not recruiting Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 2 |
| Liquidia Technologies, Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| The Cleveland Clinic | 2 |
| United Therapeutics | 2 |
| Alessandra Gorini | 1 |
| Bayer | 1 |
| Centre Hospitalier Universitaire de la Guadeloupe | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Insmed Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 22 |
| Hypertension, Pulmonary | 3 |
| Anemia, Sickle Cell | 1 |
| Connective Tissue Diseases | 1 |
| Dyslipidemias | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Heart Defects, Congenital | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Priapism | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.